trực tiếp đá gà hôm nay

ChemicalBook >> CAS DataBase List >>Exemestane

Exemestane

CAS No.
107868-30-4
Chemical Name:
Exemestane
Synonyms
AROMASIN;EXALAMIDE;Exemestan;ExeMestane(AroMasin);EXE;ROMASIN;PNU155971;FCE-24304;ExeMestine;EXEMESTANE
CBNumber:
CB5760314
Molecular Formula:
C20H24O2
Molecular Weight:
296.4
MDL Number:
MFCD00866994
MOL File:
107868-30-4.mol
Last updated:2025-01-19 18:04:22

Exemestane Properties

Melting point 155.13°C
Boiling point 453.7±45.0 °C(Predicted)
Density 1.13±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: ≥20mg/mL
form powder
color white to off-white
optical activity [α]/D +250 to +300°, c = 1 in methanol
InChI InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1
InChIKey BFYIZQONLCFLEV-DAELLWKTSA-N
SMILES C1(=O)C=C2[C@](C)(C=C1)[C@]1([H])[C@]([H])([C@@]3([H])[C@@](CC1)(C)C(=O)CC3)CC2=C
CAS DataBase Reference 107868-30-4(CAS DataBase Reference)
NCI Dictionary of Cancer Terms ;
FDA UNII
NCI Drug Dictionary
ATC code

Pharmacokinetic data

Protein binding 90%
Excreted unchanged in urine <1%
Volume of distribution 20 000 Litres
Biological half-life 24 / -

SAFETY

Risk and Safety Statements

Symbol(GHS)  trực tiếp đá gà hôm nayLiên kết đăng nhậptrực tiếp đá gà hôm nayLiên kết đăng nhập
GHS08,GHS09
Signal word  Danger
Hazard statements  H360-H411
Precautionary statements  P201-P202-P273-P280-P308+P313-P391
Hazard Codes  T,N
Risk Statements  60-61-51
Safety Statements  53-22-36/37-57
WGK Germany  3
HS Code  29372900
NFPA 704
0
2 0

Exemestane price More Price(29)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich PHR1634 Exemestane Pharmaceutical Secondary Standard; Certified Reference Material 107868-30-4 1g $112 2023-05-15 Buy
Sigma-Aldrich 1269050 Exemestane United States Pharmacopeia (USP) Reference Standard 107868-30-4 150mg $400 2023-05-15 Buy
Cayman Chemical 15008 Exemestane ≥95% 107868-30-4 5mg $43 2024-06-20 Buy
Cayman Chemical 15008 Exemestane ≥95% 107868-30-4 10mg $68 2024-06-20 Buy
Sigma-Aldrich Y0001756 Exemestane for system suitability European Pharmacopoeia (EP) Reference Standard 107868-30-4 y0001756 $218 2024-06-20 Buy
Product number Packaging Price Buy
PHR1634 1g $112 Buy
1269050 150mg $400 Buy
15008 5mg $43 Buy
15008 10mg $68 Buy
Y0001756 y0001756 $218 Buy

Exemestane Chemical Properties,Uses,Production

Indications and Usage

Exemestane is an irreversible steroid aromatase inhibitor. Its structure is similar to that of aromatase’s natural substrate, androstenedione, and acts as a pseudosubstrate. Postmenopausal women’s estrogen is mainly converted from androgen (produced by the adrenal cortex) by aromatase in the surrounding tissue. This drug irreversibly binds with the active site on aromatase to deactivate it, thus dramatically lower estrogen levels in the blood circulation of postmenopausal women. By inhibiting aromatase to lower estrogen levels, it can be used to treat hormone-dependent breast cancer in postmenopausal women.
Exemestane is suitable for treating advanced breast cancer in naturally or artificially postmenopausal women that has not responded well to tamoxifen treatment. It is also suitable for treating estrogen and progesterone receptor positive postmenopausal advanced breast cancer, and it can also be used to treat metastasized breast cancer and as adjuvant therapy for early breast cancer.

Pharmacokinetics

This drug has no noticeable effect on adrenal corticosteroids biosynthesis. Even when its concentration is over 600 times the concentration required to inhibit aromatase, it still has no noticeable effect the other enzymes in the corticosteroid production pathway.
This drug is absorbed quickly when taken orally and will affect food absorption. Its oral bioavailability is 42%. Postmenopausal women have a higher absorption rate than healthy test subjects. Patients reach peak blood concentration 2-4 hours after intake, and the peak lasts for an average of 1.2 hours, which is 2.9 hours shorter than healthy subjects. It mainly binds to Α1-acid glycoprotein and protein, and its overall binding rate to protein is 90%. It is mainly metabolized by the liver, the metabolite is inactive 17-Hydrecoxetron, and its clearing half-life is 24 hours. It is mostly excreted through urine and feces, which both account for 42% of the consumed amount.

Drug interactions

1. This drug cannot be used in combination with estrogen-based drugs to avoid counteracting its medicinal effects.
2. Exemestane is mostly metabolized by CYP3A4, but when used in combination with a strong CYP3A4 inhibitor (Ketoconazole), its pharmacokinetics do not exhibit any change. This is because the inhibitor does not seem to affect the drug’s pharmacokinetics, but it is also possible that the known CYP3A4 inducer lowers the blood concentration of Exemestane.

Side effects

Adverse effects include nausea, dryness, constipation, diarrhea, dizziness, insomnia, rash, fatigue, fever, swelling, pain, vomiting, abdominal pain, increased appetite, weight gain, etc. Additionally, some literature reports cases of hypertension, depression, anxiety, difficulty breathing, coughing, etc. There may also be decreases lymph cell amounts, abnormalities in liver function indicators (such as alanine aminotransferase), etc.

Clinical Research

For patients resistant to tamoxifen, 25mg of Exemestane, qd, can achieve an objective efficacy rate of 15-28% and a median continuation period of 69-76 weeks. Exemestane is superior to Megestrol, and it can extend the disease progression time. For patients who have worsened conditions following Megestrol treatment, Exemestane can still achieve an objective efficacy rate of 11-13%. A daily 25mg dose of Exemestane has an objective efficacy rate of 6.6% on patients who have not responded to non-steroidal aromatase inhibitors, and the two drugs are not cross-resistant.

Contradictions

1. Not to be used by patients allergic to this drug.
 2. Not to be used by pregnant women, breastfeeding women, and children.

Warnings and precautions

1. Premenopausal women usually do not use Exemestane.
2. Patients with moderate to severe liver or renal failure should use with caution. Exceeding the recommended dosage of Exemestane may increase the occurrence of nonfatal adverse effects.
3. FDA labeled this drug’s pregnancy safety as level D.
4. Elderly patients do not require any special precautions.

Description

Exemestane was launched in US and other countries for the treatment of estrogendependent tumors and postmenopausal breast cancer. It is a novel steroidal compound structurally related to the natural substrate for the biosynthesis of estrogen, androstanedione, and can be synthesized by methylidenation of androsta-1, 4-dien- 17beta-ol-3-one in 6 position then oxidation of the alcohol function. Exemestane is an irreversible inactivator of the aromatase enzyme system, so inducing in vivo a dose-related sustained suppression of serum estrogen and minimal endocrine activity. It is the first steroidal representative of the third-generation of orally active aromatase inhibitors with a highly potent and selective mechanism of action, displaying good tolerability and safety profile. In rats with DMBA-induced mammary tumors, 10 to 100 mglkg of exemestan administered po twice-daily for 4 weeks resulted in 76 to 88% regression. In women failing anti-estrogen therapy with tamoxifen, this agent has demonstrated high activity in locally advanced or metastatic disease. In addition, it may also have potential for breast cancer prevention.

Chemical Properties

white to light yellow crystal powder

Originator

Farmitalia Carlo Erba (Italy)

Uses

antiinfective

Uses

An antineoplastic (hormonal)

Uses

Labeled Exemestane, intended for use as an internal standard for the quantification of Exemestane by GC- or LC-mass spectrometry.

Definition

ChEBI: A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced brea t cancer.

Manufacturing Process

0.50 g of 6-methylenandrost-4-ene-3,17-dione and 0.57 g of dichlorodicyanobenzoquinone were refluxed in 20 ml of anhydrous dioxane for about 15 hours. To remove the DDQ the suspension was filtered through alumina. After evaporation of the solvent the residue was dissolved in ethyl acetate, the organic layer washed with water, dried over sodium sulfate and the solvent removed under vacuum. The crude product was chromatographed on silica gel using hexane/ethyl acetate to yield 0.25 g of pure 6- methylenandrosta-1,4-diene-3,17-dione, m.p. 188-191°C, λmax 247 nm (ε 13.750).

brand name

Aromasin (Pharmacia& Upjohn).

Therapeutic Function

Antineoplastic

General Description

Exemestane, 6-methylenandrosta-1,4-diene-3,17-dione (Aromasin), is the first steroid-basedaromatase inhibitor approved for the treatment of breastcancer in the United States. It is a mechanism-based inactivatorthat irreversibly inhibits the enzyme. Plasma estrogenlevels are reduced by 85% to 95% within 2 to 3 days, and effectslast 4 to 5 days. Exemestane does not inhibit any of themajor cytochromes P450 and has essentially no interactionwith steroid receptors, with only a very weak affinity for theAR. The 17β-hydroxyexemestane reduction product, however,has much higher affinity for the AR than the parent(still several fold less than DHT, 0.28% for parent vs. 30%for metabolite). The clinical significance of the affinity islikely minimal because of the low levels of the metaboliteproduced.

Hazard

A reproductive hazard.

Biochem/physiol Actions

Exemestane is a steroidal antiestrogen and irreversible aromatase inhibitor. Exemestane acts as a false substrate for the aromatase enzyme. Exemestane also prevents the conversion of androgens to estrogens and is used to treat estrogen-dependent breast cancer.

Clinical Use

Irreversible, steroidal aromatase inhibitor:
Treatment of breast cancer

Metabolism

Metabolised via oxidation by the cytochrome P450 isoenzyme CYP3A4, and via reduction by aldoketoreductase. Metabolites are excreted in the urine (39-45%) and faeces (36-48%).

References

[1] franco buzzetti, enrico di salle, antonio longo, gabriella briatico. synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione). steroids. november 1993. 58(11): 527-532.
[2] gustavo de albuquerque cavalcanti, bruno carius garrido, felipe dias leal, monica costa padilha, xavier de la torre, francisco radler de aquino neto. detection of new urinary exemestane metabolites by gas chromatography coupled to mass spectrometry. steroids. september–october 2011. 76(10-11): 1010-1015.
[3] stephanie a. jones, stephen e. jones. exemestane: a novel aromatase inactivator for breast cancer. clinical breast cancer. october 2000. 1(3): 211-216.

19457-55-7
107868-30-4
Synthesis of Exemestane from 6-METHYLENEANDROST-4-ENE-3,17-DIONE
Global( 564)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Longyu Biotechnology Co., Ltd.
+8615821988213 info@longyupharma.com China 2530 58
Changzhou Xuanming Pharmaceutical Technology Co., Ltd.
+8618068519287 sales@xuanmingchem.com China 297 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10356 58
qingdao future trading Co., Ltd
+86-13335044410 +86-13335044410 cui56813@163.com China 111 58
Hong Kong Excellence Biotechnology Co., Ltd.
+86-86-18838029171 +8618126314766 ada@sh-teruiop.com China 895 58
Hebei Mojin Biotechnology Co., Ltd
15028179902 +8615028179902 sales@hbmojin.com China 12367 58
Hebei Yanxi Chemical Co., Ltd.
+8617531190177 peter@yan-xi.com China 5907 58
Shanghai Nuo Rui Hua New Material Technology Co., Ltd
+86-15631980363 +86-15631980363 mandy@sfinechem.com China 104 58
Anhui Zhongda Biotechnology Co., Ltd
+8619956560829 justine@zhongda-biotech.com China 300 58
Anhui Ruihan Technology Co., Ltd
+8617756083858 daisy@anhuiruihan.com China 994 58

Related articles

View Lastest Price from Exemestane manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
trực tiếp đá gà hôm nayLiên kết đăng nhập 2025-01-26 exemestane
107868-30-4
US $10.00 / kg 1kg 99% 1000kg Nantong Guangyuan Pharmaceutical Technology Co,Ltd
trực tiếp đá gà hôm nayLiên kết đăng nhập 2025-01-24 Exemestane
107868-30-4
US $100.00 / kg 1kg 99.9% 20tons Hong Kong Excellence Biotechnology Co., Ltd.
trực tiếp đá gà hôm nayLiên kết đăng nhập 2025-01-21 Exemestane
107868-30-4
US $1.00 / g 1g 99.98% 50000 Doublewin Biological Technology Co., Ltd
  • trực tiếp đá gà hôm nayLiên kết đăng nhập
  • exemestane
    107868-30-4
  • US $10.00 / kg
  • 99%
  • Nantong Guangyuan Pharmaceutical Technology Co,Ltd
  • trực tiếp đá gà hôm nayLiên kết đăng nhập
  • Exemestane
    107868-30-4
  • US $100.00 / kg
  • 99.9%
  • Hong Kong Excellence Biotechnology Co., Ltd.
  • trực tiếp đá gà hôm nayLiên kết đăng nhập
  • Exemestane
    107868-30-4
  • US $1.00 / g
  • 99.98%
  • Doublewin Biological Technology Co., Ltd

Exemestane Spectrum

ExeMestane (USP) 1,4-Androstadien-3,17-dione-6-Methylene-d2 (8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione ExeMestine (8R,9S,10R,13S,14S)-10,13-diMethyl-6-Methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione ExeMestane SynonyMs 6-Methylenandrosta-1,4-diene-3,17-dione PNU155971 Exemestane for system suitability Exemestance:6-methyleneandrosta-1,4-diene-3,17-dione Exemestane D2 6-methylenandrosta-1,4-diene-3,17-dione 6-METHYLENEANDROSTA-1,4-DIENE-3,17-DIONE Exemestance 10,13-dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthrene- EXEMESTANE FCE-24304 Androsta-1,4-diene-3,17-dione, 6-methylene 6-Methyleneandrosta-1,4-diene-3,17-dione, FCE-24304, Aromasin FCE24304;FCE-24304 Exemestane(FCE 24304) 10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione Exemestane - Aromasin | FCE 24304 Exemestone EXE Aromasin/exemestane Aromasin CAS 107868-30-4 Exemestane CRS Exemestane for system suitability CRS [2H2]-Exemestane Aromasin Exeme Acatate? Exemestane USP/EP/BP Steroids Raw Powder Hormone Exemestane, Aromasin Exemestane(USFDA/CEP) ROMASIN Exemestane (Aromasin,EXE)-1 gram(17) ExemestaneQ: What is Exemestane Q: What is the CAS Number of Exemestane Q: What is the storage condition of Exemestane Q: What are the applications of Exemestane Exemestane for system suitability (Y0001756) Exemestane 13C D2Q: What is Exemestane 13C D2 Q: What is the CAS Number of Exemestane 13C D2 Q: What is the storage condition of Exemestane 13C D2 Q: What are the applications of Exemestane 13C D2 Exemestane D2Q: What is Exemestane D2 Q: What is the CAS Number of Exemestane D2 Q: What is the storage condition of Exemestane D2 Q: What are the applications of Exemestane D2 Exemestane (1269050) ExeMestane(AroMasin) Exemestan AROMASIN EXALAMIDE Exemestane 107868-30-4 Aromasin / Exemestan / Exemestane 107868-30-4 156-1-31 7868-30-4 107968-30-4 C20H24O2 2964 Intermediates & Fine Chemicals Pharmaceuticals Steroids Pfizer compounds Steroid and Hormone API
trò chơi cờ bạc game điện tử máy đánh bạc máy đánh bạc hoàng gia Tải game ăn tiền thật